Hypothesis / aims of study
Urethral atrophy remains a common cause of recurrent stress urinary incontinence (SUI) following artificial urinary sphincter (AUS) implantation. Traditional management strategies include cuff downsizing, tandem cuff implantation, transcorporal cuff placement, or cuff relocation. We describe a novel AUS revision technique utilizing the mature pseudocapsule formed around the original cuff to restore urethral bulk while minimizing perineal dissection.
Study design, materials and methods
A retrospective chart review was performed of patients undergoing AUS revision for management of recurrent SUI due to urethral atrophy between September 2005 and March 2025. Inclusion criteria consisted of men with urethral atrophy and recurrent SUI who underwent surgical AUS revision utilizing the existing bulbar urethral pseudocapsule with a minimum follow-up of 12 months. Patient demographics, medical and surgical history, pad usage, complications, and follow-up data were collected. Surgical technique - following explantation of the original cuff, the well-formed fibrous pseudocapsule surrounding the bulbar urethra was carefully preserved. The new AUS cuff was then placed around the bulbar urethra and ventral segment of the pseudocapsule, thereby increasing urethral bulk and improving urethral coaptation. Other AUS components were replaced at the surgeon’s discretion.
Results
A total of 29 patients met inclusion criteria. Initial causes of SUI included radical prostatectomy (11), pelvic radiation (4), combined radical prostatectomy and pelvic radiation (12), or pelvic fracture (2). The mean age at original AUS placement was 67.1 years (range 49 – 76). Median cuff size was 4cm (range 3.5 – 5). Prior to surgical revision, average daily pad usage and pad weight were 4.5 (range 2 – 8) and 423g (range 130 – 990). Mean time to revision surgery was 5.1 years (range 2.3 – 13.8) after original AUS placement. Median replacement cuff size was 4.5cm (range 4 - 5). With a mean follow up of 42.0 months (range 12 – 116), average daily pad usage and pad weight decreased to 0.9 (range 0 – 2) and 29g (range 0 – 147) (p < 0.05). Two patients underwent device explanation due to infection within two months of surgical revision. Two additional patients underwent AUS explantation secondary to cuff erosion after urethral catheter placement.
Interpretation of results
A statistically significant reduction in pad usage and pad weight were noted following AUS revision for urethral atrophy utilizing the original cuff pseudocapsule. Incorporating the mature fibrous tissue into the revision helps provide urethral bulk, coaptation, and may preserve urethral integrity. Furthermore, more extensive urethral dissection, as required with transcorporal cuff placement or cuff relocation, is avoided. Finally, the technique is particularly useful in patients when cuff downsizing or transcorporal placement may not be feasible.